Last Updated: August 2, 2026

CYPROHEPTADINE HYDROCHLORIDE Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Cyproheptadine Hydrochloride, and when can generic versions of Cyproheptadine Hydrochloride launch?

Cyproheptadine Hydrochloride is a drug marketed by Actavis Mid Atlantic, Chartwell Molecular, Halsey, Morton Grove, Naska, Patrin, Pharm Assoc, Quagen, Rising, St John Pharm, Tris Pharma Inc, Am Therap, Anvi, Appco, Ascot, Chartwell Rx, Duramed Pharms Barr, Heritage Pharma, Ingenus Pharms Llc, Kenton, Kv Pharm, Md Pharm, Mountain, Mylan, Pioneer Pharms, Pliva, Regcon Holdings, Strides Pharma Intl, Superpharm, Vitarine, Watson Labs, and Zydus Pharms. and is included in thirty-nine NDAs.

The generic ingredient in CYPROHEPTADINE HYDROCHLORIDE is cyproheptadine hydrochloride. There are six drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the cyproheptadine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Cyproheptadine Hydrochloride

A generic version of CYPROHEPTADINE HYDROCHLORIDE was approved as cyproheptadine hydrochloride by CHARTWELL RX on May 26^th, 1983.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for CYPROHEPTADINE HYDROCHLORIDE?
What are the global sales for CYPROHEPTADINE HYDROCHLORIDE?
What is Average Wholesale Price for CYPROHEPTADINE HYDROCHLORIDE?

Summary for CYPROHEPTADINE HYDROCHLORIDE

US Patents:	0
Applicants:	32
NDAs:	39

US Patents and Regulatory Information for CYPROHEPTADINE HYDROCHLORIDE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Rising	CYPROHEPTADINE HYDROCHLORIDE	cyproheptadine hydrochloride	TABLET;ORAL	207783-001	Dec 29, 2016		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Pliva	CYPROHEPTADINE HYDROCHLORIDE	cyproheptadine hydrochloride	TABLET;ORAL	088205-001	Jul 26, 1983		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Strides Pharma Intl	CYPROHEPTADINE HYDROCHLORIDE	cyproheptadine hydrochloride	TABLET;ORAL	209172-001	Apr 11, 2018	AA	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Quagen	CYPROHEPTADINE HYDROCHLORIDE	cyproheptadine hydrochloride	TABLET;ORAL	212491-001	Feb 24, 2021	AA	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Actavis Mid Atlantic	CYPROHEPTADINE HYDROCHLORIDE	cyproheptadine hydrochloride	SYRUP;ORAL	086833-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Duramed Pharms Barr	CYPROHEPTADINE HYDROCHLORIDE	cyproheptadine hydrochloride	TABLET;ORAL	088232-001	Oct 25, 1983		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.